Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 241
Gene Symbol: ALOX5AP
ALOX5AP
0.370 Biomarker disease CTD_human
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.360 Biomarker disease CTD_human
Entrez Id: 2147
Gene Symbol: F2
F2
0.350 Biomarker disease CTD_human
Entrez Id: 2153
Gene Symbol: F5
F5
0.340 Biomarker disease CTD_human
Entrez Id: 5583
Gene Symbol: PRKCH
PRKCH
0.330 Biomarker disease CTD_human
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.050 Biomarker disease BEFREE <b><i>Conclusions:</i> Oral health measured by number of tooth extractions >10 was an independent predictor for cerebral infarction in addition to age, HDL-C, hs-C-reactive protein and diabetes. 31814529 2019
Entrez Id: 1520
Gene Symbol: CTSS
CTSS
0.020 GeneticVariation disease BEFREE <b>Conclusion:</b> The single nucleotide polymorphisms (SNPs) of rs774320676 and rs928508030 of <i>CTSS</i> gene were related with risk for acute atherosclerotic cerebral infarction. 30341237 2018
Entrez Id: 2309
Gene Symbol: FOXO3
FOXO3
0.020 Biomarker disease BEFREE <b>Conclusion:</b> These data revealed an important role of FoxO3 in regulating autophagy in brain, and provided a new approach for further prevention and treatment of cerebral ischemia. 30595062 2019
Entrez Id: 7066
Gene Symbol: THPO
THPO
0.010 Biomarker disease BEFREE <b>Objective:</b> To determine the neuroprotective effects and underpinning mechanisms of thrombopoietin (TPO), Matrix Metalloproteinase-9(MMP-9) and Nuclear Factor-κB (NF-κB) after focal cerebral ischemia-reperfusion in rats. 30275761 2018
Entrez Id: 4318
Gene Symbol: MMP9
MMP9
0.100 Biomarker disease BEFREE <b>Objective:</b> To determine the neuroprotective effects and underpinning mechanisms of thrombopoietin (TPO), Matrix Metalloproteinase-9(MMP-9) and Nuclear Factor-κB (NF-κB) after focal cerebral ischemia-reperfusion in rats. 30275761 2018
Entrez Id: 100128998
Gene Symbol: C20orf181
C20orf181
0.100 Biomarker disease BEFREE <b>Results:</b><i>In vitro</i>, plasmin activity assays showed that the combination of t-PA with DHI at about 1:1.6 w/v ratio increased by almost 1.4-fold the plasmin-generating capability of t-PA. <i>In vivo</i> experiments, the results showed that the combination of Danhong injection (4 mL/kg) and t-PA (2.5 mg/kg) could extend the t-PA treatment time windows to 4.5 h. And the combination t-PA (2.5 mg/kg) with DHI (4 mL/kg) ameliorated neurological score, cerebral infarction, brain edema, brain hemorrhage, and BBB disruption. 29681849 2018
Entrez Id: 59272
Gene Symbol: ACE2
ACE2
0.010 Biomarker disease BEFREE (3) Transfusion of lentivirus-ACE2-primed EPCs reduced cerebral infarct volume and neurological deficits, and increased cerebral microvascular density and angiogenesis. 23266545 2013
Entrez Id: 51192
Gene Symbol: CKLF
CKLF
0.020 Biomarker disease BEFREE (4) Conclusions: The present study suggested that the protective mechanism of IMM-H004 is dependent on CKLF1, which will lead to excessive inflammatory response in cerebral ischemia. 30987181 2019
Entrez Id: 58157
Gene Symbol: NGB
NGB
0.050 Biomarker disease BEFREE 14-3-3gamma and neuroglobin are new intrinsic protective factors for cerebral ischemia. 20467836 2010
Entrez Id: 57556
Gene Symbol: SEMA6A
SEMA6A
0.020 Biomarker disease BEFREE 3-N-butylphthalide inhibits neuronal apoptosis in rats with cerebral infarction via targeting P38/MAPK. 31389585 2019
Entrez Id: 4780
Gene Symbol: NFE2L2
NFE2L2
0.100 Biomarker disease BEFREE 5-HMF attenuates striatum oxidative damage via Nrf2/ARE signaling pathway following transient global cerebral ischemia. 27812888 2017
Entrez Id: 2551
Gene Symbol: GABPA
GABPA
0.100 Biomarker disease BEFREE 5-HMF attenuates striatum oxidative damage via Nrf2/ARE signaling pathway following transient global cerebral ischemia. 27812888 2017
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1
0.020 GeneticVariation disease BEFREE Cerebral infarction in a heterozygote with variant antithrombin III. 1448834 1992
Entrez Id: 26073
Gene Symbol: POLDIP2
POLDIP2
0.020 AlteredExpression disease BEFREE Cerebral ischemia induced the expression of Poldip2. 29452577 2018
Entrez Id: 5327
Gene Symbol: PLAT
PLAT
0.390 GeneticVariation disease BEFREE Cerebral ischemia causes the presynaptic release of tissue-type plasminogen activator (tPA). 29547062 2018
Entrez Id: 6833
Gene Symbol: ABCC8
ABCC8
0.030 Biomarker disease BEFREE Cerebral ischemia/reperfusion is characterized by SUR1-TRPM4 (sulfonylurea receptor 1-transient receptor potential melastatin 4) channel upregulation in microvascular endothelium. 29617457 2018
Entrez Id: 5978
Gene Symbol: REST
REST
0.040 Biomarker disease BEFREE Cerebral ischemia is known to activate the repressor element-1 (RE1)-silencing transcription factor (REST) which silences neural genes via epigenetic remodeling and promotes neurodegeneration. 30039336 2019
Entrez Id: 7225
Gene Symbol: TRPC6
TRPC6
0.030 Biomarker disease BEFREE Cerebral ischemia induces TRPC6 via HIF1α/ZEB2 axis in the glomerular podocytes and contributes to proteinuria. 31784544 2019
Entrez Id: 4953
Gene Symbol: ODC1
ODC1
0.010 AlteredExpression disease BEFREE Cerebral ischemia causes activation of ornithine decarboxylase (ODC) gene and subsequent accumulation of putrescine, which might either directly or indirectly affect the outcome of cerebral infarct. 9056624 1997
Entrez Id: 348
Gene Symbol: APOE
APOE
0.100 GeneticVariation disease BEFREE Apo E genotypes were not related to the pathological type of stroke (cerebral infarction, CI, n = 532 and primary intracranial haemorrhage, PICH, n = 60, (chi2 =3.738, 4 d.f., P=0.44) nor with the Oxfordshire Community Stroke Project Classification subtypes of cerebral infarction, lacunar infarction, LACI (n = 169), total anterior circulation infarction, TACI (n = 117), partial anterior circulation infarction, PACI (n = 173), posterior circulation infarction, POCS (n = 54) and including those cerebral infarcts which could not be classified (n= 19), chi2 =31.1, 20 d.f., P=0.153). 10877158 2000